02 June 2022
: Case report
[In Press] Recurrent Myocarditis Treated with Intravenous Immune Globulin and Steroids
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease
Brandon H. Schwartz1AEF, Nathan R. Stein2E, Shervin Eshaghian2E, Alan C. Kwan
DOI: 10.12659/AJCR.935974
Am J Case Rep In Press; DOI: 10.12659/AJCR.935974
Available online: 2022-06-02, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Myocarditis is an inflammatory process that can present as acute or chronic with either focal or diffuse involvement of the myocardium. Its incidence is approximately 1.5 million cases per year worldwide. In the United States, viral infection is the most common cause of myocarditis. Most of the reported cases are singular and self-limiting in nature. We present the case of severe recurrent myocarditis in a young adult who was transferred to the Intensive Care Unit.
CASE REPORT
An 18-year-old man presented with chest pressure and troponin I 33 ng/mL. He had presented to another hospital with similar symptoms 3 months prior and was diagnosed with myocarditis that had resolved with colchicine. As part of his workup during this admission, coronary angiogram was normal and biopsy obtained without evidence of an inflammatory process; however, cardiac magnetic resonance imaging (MRI) was consistent with myocarditis and Coxsackie B titers indicated prior infection, leading to a diagnosis of clinically suspected recurrent viral myocarditis. He was treated with intravenous immunoglobulin (IV Ig) and a steroid taper, with rapid improvement in symptoms over the ensuing weeks without evidence of further recurrence or sequelae.
CONCLUSIONS
We present a case of recurrent Coxsackie B myocarditis based on presentation and imaging. Myocarditis is an important diagnosis to consider when a young, healthy individual presents with chest pain mimicking acute coronary syndrome, especially during the COVID pandemic. If there is evidence of myocarditis on MRI or endomyocardial biopsy, immunosuppressive therapy should be considered in patients with recurrent and severe presentations.
Keywords: Chest Pain; Coxsackievirus Infections; Immunoglobulins, Intravenous; Myocarditis
SARS-CoV-2/COVID-19
16 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936498
13 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936889
13 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936128
03 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936832
In Press
24 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936288
24 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936641
24 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936513
22 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936862
Most Viewed Current Articles
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
09 Feb 2022 : Case report
DOI :10.12659/AJCR.934744
Am J Case Rep 2022; 23:e934744